Literature DB >> 29277275

Towards standardized criteria for diagnosing chronic intervillositis of unknown etiology: A systematic review.

M Bos1, P G J Nikkels2, D Cohen3, J W Schoones4, K W M Bloemenkamp5, J A Bruijn3, H J Baelde3, M L P van der Hoorn6, R J Turner3.   

Abstract

Chronic intervillositis of unknown etiology (CIUE) is a poorly understood, relatively rare condition characterized histologically by the intervillous infiltration of mononuclear cells in the placenta. Clinically, CIUE is associated with poor pregnancy outcome (e.g., impaired fetal growth, preterm birth, fetal death) and high risk of recurrence in subsequent pregnancies. Because CIUE is not defined consistently, it is essential to clearly define this condition. We therefore review the published definitions of CIUE. In addition, we provide an overview of the reviewed histopathological and maternal characteristics, obstetric features, and pregnancy outcomes. Medical publication databases were searched for articles published through February 2017. Eighteen studies were included in our systematic review. The sole inclusion criterion used in all studies was the presence of intervillous infiltrates. Overall, CIUE was characterized by adverse pregnancy outcome. Miscarriage occurred in 24% of cases, with approximately half of these miscarriages defined as late. Impaired growth was commonly observed, 32.4% of pregnancies reached term, and the live birth rate was 54.9%. The high recurrence rate (25.1%) of the intervillous infiltrates in subsequent pregnancies underscores the clinical relevance of CIUE, the need for increased awareness among pathologists and clinicians, and the need for further research. Criteria for the diagnosis of CIUE are proposed and a Delphi study could be used to resolve any controversy regarding these criteria. Future studies should be designed to characterize the full clinical spectrum of CIUE.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Chronic intervillositis; Chronic intervillositis of unknown etiology; Fetal loss; Intra uterine growth restriction; Miscarriage; Small for gestational age

Mesh:

Year:  2017        PMID: 29277275     DOI: 10.1016/j.placenta.2017.11.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  16 in total

1.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

2.  Histopathological features in advanced abdominal pregnancies co-infected with SARS-CoV-2 and HIV-1 infections: A case evaluation.

Authors:  S Ramphal; N Govender; S Singh; O P Khaliq; T Naicker
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2022-05-14

3.  Hypertensive disease, preterm birth, fetal growth restriction and chronic inflammatory disorders of the placenta: experiences in a single institution with a standardized protocol of investigation.

Authors:  Henning Feist; Simin Bajwa; Ulrich Pecks
Journal:  Arch Gynecol Obstet       Date:  2021-10-24       Impact factor: 2.493

4.  One-Sided Chronic Intervillositis of Unknown Etiology in Dizygotic Twins: A Description of 3 Cases.

Authors:  Lotte E van der Meeren; Juliette Krop; Kyra L Dijkstra; Kitty W M Bloemenkamp; Emily F Cornish; Peter G J Nikkels; Marie-Louise P van der Hoorn; Manon Bos
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 5.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

6.  Errors in search strategies used in systematic reviews and their effects on information retrieval.

Authors:  José Antonio Salvador-Oliván; Gonzalo Marco-Cuenca; Rosario Arquero-Avilés
Journal:  J Med Libr Assoc       Date:  2019-04-01

Review 7.  Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.

Authors:  Jeffery A Goldstein; Kelly Gallagher; Celeste Beck; Rajesh Kumar; Alison D Gernand
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

Review 8.  Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.

Authors:  David A Schwartz; Denise Morotti
Journal:  Viruses       Date:  2020-11-15       Impact factor: 5.048

Review 9.  The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes.

Authors:  Alexandra Bouariu; Nicolae Gică; Anca Marina Ciobanu; Ana Maria Scutelnicu; Mihaela Roxana Popescu; Anca Maria Panaitescu
Journal:  Healthcare (Basel)       Date:  2022-01-17

10.  SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.

Authors:  Jonathon L Hecht; Bradley Quade; Vikram Deshpande; Mari Mino-Kenudson; David T Ting; Niyati Desai; Beata Dygulska; Taryn Heyman; Carolyn Salafia; Dejun Shen; Sara V Bates; Drucilla J Roberts
Journal:  Mod Pathol       Date:  2020-08-02       Impact factor: 8.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.